Vol. 102 No. 8 (2017): August, 2017 | Haematologica
Cancers | Free Full-Text | Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia
Frontiers | Understanding blood development and leukemia using sequencing-based technologies and human cell systems
![PDF] Pathophysiology and treatment of patients with beta-thalassemia – an update | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/44d24730e45badafae7882562e6d62f83daf7632/8-Figure1-1.png "PDF] Pathophysiology and treatment of patients with beta-thalassemia – an update | Semantic Scholar")
PDF] Pathophysiology and treatment of patients with beta-thalassemia – an update | Semantic Scholar
PDF) The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia
Haematologica, Volume 107, Issue 6 by Haematologica - Issuu
Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates: Molecular Therapy - Methods & Clinical Development
Haematologica, Volume 102, issue 11 by Haematologica - Issuu
Haematologica, Volume 104, Issue 3 by Haematologica - Issuu
Haematologica, Volume 107, Issue 11 by Haematologica - Issuu
Haematologica, Volume 107, Issue 7 by Haematologica - Issuu
Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin | Haematologica
The evolving treatment landscape for children with sickle cell disease - The Lancet Child & Adolescent Health
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin | Haematologica
Haematologica, Volume 107, Issue 11 by Haematologica - Issuu
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Haematologica, Volume 106, Issue 2 by Haematologica - Issuu
Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E/β-thalassemia patient | Scientific Reports
Haematologica, Volume 104, Issue 5 by Haematologica - Issuu
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission - The Lancet Haematology
Haematologica, Volume 106, Issue 9 by Haematologica - Issuu
PDF) How I treat and monitor non-transfusion-dependent thalassaemia
New therapeutic targets in transfusion-dependent and -independent thalassemia. - Abstract - Europe PMC
Vol. 102 No. 4 (2017): April, 2017 | Haematologica
